Webinar - Hybrid: Go-To-Market Models, Roles, and Capabilities for HCP Engagement
May 12, 2021
Join this exclusive webinar as we discuss the future of hybrid HCP engagement and go-to-market models.
Hybrid: Go-To-Market Models, Roles, and Capabilities for HCP Engagement
Hybrid. Who knew a year ago this unremarkable word would have such a large part to play in pharma’s future lexicon and strategy building?
But here we are. Executives across the industry are working tirelessly to devise and execute a model in which pharma sales representatives and other customer facing roles balance face-to-face (F2F), remote, and digital engagement, whilst also considering to what extent the roles themselves must be adapted for the new normal.
Many questions remain unanswered:
How can we ensure that we are reaching HCPs at a time and place where they can truly engage?
What is the right balance of F2F and remote engagement?
How do you create and maintain new relationships in the remote environment?
How can we demonstrate what does - and doesn’t - and rapidly adapt and improve?
Join this exclusive webinar as we discuss the future of hybrid HCP engagement and go-to-market models. Key learnings include:
• HCP engagement capabilities and roles: How to combine F2F, remote, and digital engagement strategies for a comprehensive hybrid go-to-market model – the key principles apply across brands and therapy areas
• Content HCPs care about: How to raise the bar on addressing HCPs needs with tailored and relevant content and offerings
• Do it with data and technology: Ensure adjusting to HCP needs and preferences by defining the next-best action with a clear understanding of the HCP’s context
George Katzourakis, SVP, Head of Europe, GSK
Cyril Schiever, SVP, President Mid-Europe Region, MSD
Janneke van der Kamp, Head, Region Europe, Novartis
Brent Hooper, Partner, McKinsey
Yashaswi Gautam, Partner, McKinsey
Christina Hoffman, Associate Partner, McKinsey